Page 1 | Search Results | Diabetes | American Diabetes Association

1-20 of 158

Sort by

Sort Order Select

Meeting Abstracts

1259-P: Resting Heart Rate and Sleep Disorders in Maturity-Onset Diabetes of the Young

MARILYN A. AROSEMENA, KRISTEN WROBLEWSKI, ESRA TASALI, LOUIS H. PHILIPSON

Diabetes 2023;72(Supplement_1):1259-P

https://doi.org/10.2337/db23-1259-P

Published: 20 June 2023

View article titled, 1259-P: Resting Heart Rate and Sleep Disorders in Maturity-Onset Diabetes of the Young

Meeting Abstracts

1035-P: Area Deprivation Index and Rates of Specialty Care in Monogenic Diabetes Registry Participants

RACHEL G. SON, ROCHELLE N. NAYLOR, STUDY GROUP UNIVERSITY OF CHICAGO MONOGENIC DIABETES REGISTRY

Diabetes 2023;72(Supplement_1):1035-P

https://doi.org/10.2337/db23-1035-P

Published: 20 June 2023

View article titled, 1035-P: Area Deprivation Index and Rates of Specialty Care in Monogenic Diabetes Registry Participants

Meeting Abstracts

1465-P: Identification of GCK Gene Variants and Clinical Characterization in Japanese Pediatric MODY2 Cases

RUMI KATASHIMA, SUMIKO YOSHIDA, YUKA WATANABE, MAKI MORITANI, ICHIRO YOKOTA

Diabetes 2023;72(Supplement_1):1465-P

https://doi.org/10.2337/db23-1465-P

Published: 20 June 2023

View article titled, 1465-P: Identification of GCK Gene Variants and Clinical Characterization in Japanese Pediatric MODY2 Cases

Meeting Abstracts

503-P: Distinct Effects of a Novel GCK-MODY Mutation on Lipid Profiles and Diabetic Complications

YADI HUANG, YUXIN FAN, XIN LI, SHUHUI JI, SHANSHAN CHEN, JINGQIU CUI, WENLI FENG, HUA SHU, MING LIU

Diabetes 2023;72(Supplement_1):503-P

https://doi.org/10.2337/db23-503-P

Published: 20 June 2023

View article titled, 503-P: Distinct Effects of a Novel GCK-MODY Mutation on Lipid Profiles and Diabetic Complications

Meeting Abstracts

221-OR: Retrospective Review of Genetic Mutations and Treatments in Patients with Monogenic Diabetes of the Youth (MODY)

LILY DENG, AMY S. SHAH, MANSA KRISHNAMURTHY

Diabetes 2023;72(Supplement_1):221-OR

https://doi.org/10.2337/db23-221-OR

Published: 20 June 2023

View article titled, 221-OR: Retrospective Review of Genetic Mutations and Treatments in Patients with Monogenic Diabetes of the Youth (MODY)

Meeting Abstracts

1475-P: Novel Mutations in the Wolframin Gene with Diabetes—A Case Series of a Potential Addition to the Monogenic Diabetes Profile

ZACHARY YIN, ABDULLAH A. NOOR, KARINA G. ROMO, SNEHA BHAMRE, MARY GABRIEL, TANAYA PULISETTY, SHARON SHU, GABRIEL I. UWAIFO

Diabetes 2023;72(Supplement_1):1475-P

https://doi.org/10.2337/db23-1475-P

Published: 20 June 2023

View article titled, 1475-P: Novel Mutations in the Wolframin Gene with Diabetes—A Case Series of a Potential Addition to the Monogenic Diabetes Profile

Meeting Abstracts

1281-P: Variants of Unknown Significance (VUS) in Maturity-Onset Diabetes of the Young (MODY)—High Rate of Conundrum Resolution via Reanalysis of VUS

GUIDO ALARCON, MARIA J. REDONDO, MUSTAFA TOSUR

Diabetes 2023;72(Supplement_1):1281-P

https://doi.org/10.2337/db23-1281-P

Published: 20 June 2023

View article titled, 1281-P: Variants of Unknown Significance (VUS) in Maturity-Onset Diabetes of the Young (MODY)—High Rate of Conundrum Resolution via Reanalysis of VUS

Meeting Abstracts

1280-P: The Maturity-Onset Diabetes of the Young (MODY) Calculator Overestimates MODY Probability in Hispanic Youth

GUIDO ALARCON, ANH D. NGUYEN, ANGUS JONES, MARIA J. REDONDO, BEVERLEY SHIELDS, MUSTAFA TOSUR

Diabetes 2023;72(Supplement_1):1280-P

https://doi.org/10.2337/db23-1280-P

Published: 20 June 2023

View article titled, 1280-P: The Maturity-Onset Diabetes of the Young (MODY) Calculator Overestimates MODY Probability in Hispanic Youth

Meeting Abstracts

1550-P: A Gain-of-Function Maturity-Onset Diabetes of the Young (MODY)–Associated TALK1 Mutation Impairs Glucose Metabolism in Mice

WEN-HAO TSAI, SHI-BING YANG

Diabetes 2023;72(Supplement_1):1550-P

https://doi.org/10.2337/db23-1550-P

Published: 20 June 2023

View article titled, 1550-P: A Gain-of-Function Maturity-Onset Diabetes of the Young (MODY)–Associated TALK1 Mutation Impairs Glucose Metabolism in Mice

Journal Articles

A Comparison of Daily Glucose Fluctuation Between GCK-MODY and Type 2 Diabetes Using Continuous Glucose Monitoring Technology

Qian Ren, Ping Zhang, Wuyan Pang, Yumin Ma, Siqian Gong, Tianhao Ba, Wei Liu, Fang Zhang, Xiuying Zhang, Rui Zhang, Xiangqing Wang, Xiaomei Zhang, Wenjia Yang, Fang Lv, Leili Gao, Xueyao Han, Linong Ji

Diabetes 2023;72(6):812–818

https://doi.org/10.2337/db22-0566

Published: 20 March 2023

View article titled, A Comparison of Daily Glucose Fluctuation Between GCK-MODY and Type 2 Diabetes Using Continuous Glucose Monitoring Technology

Journal Articles

Dorzagliatin, a Dual-Acting Glucokinase Activator, Increases Insulin Secretion and Glucose Sensitivity in Glucokinase Maturity-Onset Diabetes of the Young and Recent-Onset Type 2 Diabetes

Elaine Chow, Ke Wang, Cadmon K.P. Lim, Sandra T.F. Tsoi, Baoqi Fan, Emily Poon, Andrea O.Y. Luk, Ronald C.W. Ma, Ele Ferrannini, Andrea Mari, Li Chen, Juliana C.N. Chan

Diabetes 2023;72(2):299–308

https://doi.org/10.2337/db22-0708

Published: 28 October 2022

View article titled, Dorzagliatin, a Dual-Acting Glucokinase Activator, Increases Insulin Secretion and Glucose Sensitivity in Glucokinase Maturity-Onset Diabetes of the Young and Recent-Onset Type 2 Diabetes

Journal Articles

Response to Comment on Colclough et al. and Saint-Martin et al. Syndromic Monogenic Diabetes Genes Should Be Tested in Patients With a Clinical Suspicion of Maturity-Onset Diabetes of the Young. Diabetes 2022;71:530–537, and Gene Panel Sequencing of Patients With Monogenic Diabetes Brings to Light Genes Typically Associated With Syndromic Presentations. Diabetes 2022;71:578–584

Kevin Colclough, Kashyap Patel

Diabetes 2022;71(9):e11–e12

https://doi.org/10.2337/db22-0400

Published: 11 August 2022

View article titled, Response to Comment on Colclough et al. and Saint-Martin et al. Syndromic Monogenic Diabetes Genes Should Be Tested in Patients With a Clinical Suspicion of Maturity-Onset Diabetes of the Young. Diabetes 2022;71:530–537, and Gene Panel Sequencing of Patients With Monogenic Diabetes Brings to Light Genes Typically Associated With Syndromic Presentations. Diabetes 2022;71:578–584

Journal Articles

Comment on Colclough et al. and Saint-Martin et al. Syndromic Monogenic Diabetes Genes Should Be Tested in Patients With a Clinical Suspicion of Maturity-Onset Diabetes of the Young. Diabetes 2022;71:530–537, and Gene Panel Sequencing of Patients With Monogenic Diabetes Brings to Light Genes Typically Associated With Syndromic Presentations. Diabetes 2022;71:578–584

Su Fen Ang, Su Chi Lim

Diabetes 2022;71(9):e9–e10

https://doi.org/10.2337/db22-0305

Published: 11 August 2022

View article titled, Comment on Colclough et al. and Saint-Martin et al. Syndromic Monogenic Diabetes Genes Should Be Tested in Patients With a Clinical Suspicion of Maturity-Onset Diabetes of the Young. Diabetes 2022;71:530–537, and Gene Panel Sequencing of Patients With Monogenic Diabetes Brings to Light Genes Typically Associated With Syndromic Presentations. Diabetes 2022;71:578–584

Meeting Abstracts

261-OR: Dorzagliatin, a Dual-Acting Glucokinase Activator. Improves Insulin Secretion and Glucose Sensitivity in Glucokinase-Maturity-Onset Diabetes of the Young (GCK-MODY)

ELAINE CHOW, KE WANG, CADMON K.P. LIM, SANDRA TSOI, BAOQI FAN, ANDREA LUK, RONALD C. MA, ELE FERRANNINI, ANDREA MARI, LI CHEN, JULIANA C. CHAN

Diabetes 2022;71(Supplement_1):261-OR

https://doi.org/10.2337/db22-261-OR

Published: 01 June 2022

View article titled, 261-OR: Dorzagliatin, a Dual-Acting Glucokinase Activator. Improves Insulin Secretion and Glucose Sensitivity in Glucokinase-Maturity-Onset Diabetes of the Young (GCK-MODY)

Meeting Abstracts

182-OR: Clinical Effects of SGLT2 Inhibitors in HNF1A-Diabetes (MODY3) : A Case Series

HENRIK MAAGENSEN, SOFIE HAEDERSDAL, JESPER KROGH, TORBEN HANSEN, FILIP K. KNOP, TINA VILSBØLL

Diabetes 2022;71(Supplement_1):182-OR

https://doi.org/10.2337/db22-182-OR

Published: 01 June 2022

View article titled, 182-OR: Clinical Effects of SGLT2 Inhibitors in HNF1A-Diabetes (MODY3) : A Case Series

Meeting Abstracts

1274-P: Prevalence and Clinical Characteristics of Monogenic Diabetes in Chinese Population

SANDRA TSOI, CADMON K. LIM, RONALD C. MA, ERIC S. LAU, BAOQI FAN, ELAINE CHOW, ALICE P. KONG, JULIANA C. CHAN, ANDREA LUK

Diabetes 2022;71(Supplement_1):1274-P

https://doi.org/10.2337/db22-1274-P

Published: 01 June 2022

View article titled, 1274-P: Prevalence and Clinical Characteristics of Monogenic Diabetes in Chinese Population

Meeting Abstracts

149-OR: Genetic Modulation of HNF1A Activity via SGLT2 Deficiency Leads to Transient Intermittent Hyperglycemia: Consequences for HNF1A-MODY

ANA ACOSTA-MONTALVO, CHIARA SAPONARO, JULIEN THEVENET, MAGALI CHIRAL, ANTHONY PIRON, NATHALIE DELALLEAU, GIANNI PASQUETTI, ANAÏS CODDEVILLE, MARIA MORENO, VALERY GMYR, MIRIAM CNOP, JULIE A. KERR-CONTE, FRANCOIS PATTOU, MARCO PONTOGLIO, ADRIAN LISTON, CAROLINE BONNER

Diabetes 2022;71(Supplement_1):149-OR

https://doi.org/10.2337/db22-149-OR

Published: 01 June 2022

View article titled, 149-OR: Genetic Modulation of HNF1A Activity via SGLT2 Deficiency Leads to Transient Intermittent Hyperglycemia: Consequences for HNF1A-MODY

Meeting Abstracts

257-LB: A Novel MODY-Associated Gain-of-Function Mutation in TALK-1 Leads to Islet Dysfunction and Glucose Intolerance

ARYA Y. NAKHE, PRASANNA DADI, KAROLINA E. ZABORSKA, DAVID JACOBSON

Diabetes 2022;71(Supplement_1):257-LB

https://doi.org/10.2337/db22-257-LB

Published: 01 June 2022

View article titled, 257-LB: A Novel MODY-Associated Gain-of-Function Mutation in TALK-1 Leads to Islet Dysfunction and Glucose Intolerance

Meeting Abstracts

1290-P: A Rare Case of HNF1A-MODY

SARA VELAYATI, MICHAEL SHANIK, ISABELA J. ROMAO

Diabetes 2022;71(Supplement_1):1290-P

https://doi.org/10.2337/db22-1290-P

Published: 01 June 2022

View article titled, 1290-P: A Rare Case of HNF1A-MODY

Journal Articles

Evaluation of Evidence for Pathogenicity Demonstrates That BLK, KLF11, and PAX4 Should Not Be Included in Diagnostic Testing for MODY

Thomas W. Laver, Matthew N. Wakeling, Olivia Knox, Kevin Colclough, Caroline F. Wright, Sian Ellard, Andrew T. Hattersley, Michael N. Weedon, Kashyap A. Patel

Diabetes 2022;71(5):1128–1136

https://doi.org/10.2337/db21-0844

Published: 02 February 2022

View article titled, Evaluation of Evidence for Pathogenicity Demonstrates That BLK, KLF11, and PAX4 Should Not Be Included in Diagnostic Testing for MODY

NARROW

1259-P: Resting Heart Rate and Sleep Disorders in Maturity-Onset Diabetes of the Young

1035-P: Area Deprivation Index and Rates of Specialty Care in Monogenic Diabetes Registry Participants

1465-P: Identification of GCK Gene Variants and Clinical Characterization in Japanese Pediatric MODY2 Cases

503-P: Distinct Effects of a Novel GCK-MODY Mutation on Lipid Profiles and Diabetic Complications

221-OR: Retrospective Review of Genetic Mutations and Treatments in Patients with Monogenic Diabetes of the Youth (MODY)

1475-P: Novel Mutations in the Wolframin Gene with Diabetes—A Case Series of a Potential Addition to the Monogenic Diabetes Profile

1281-P: Variants of Unknown Significance (VUS) in Maturity-Onset Diabetes of the Young (MODY)—High Rate of Conundrum Resolution via Reanalysis of VUS

1280-P: The Maturity-Onset Diabetes of the Young (MODY) Calculator Overestimates MODY Probability in Hispanic Youth

1550-P: A Gain-of-Function Maturity-Onset Diabetes of the Young (MODY)–Associated TALK1 Mutation Impairs Glucose Metabolism in Mice

A Comparison of Daily Glucose Fluctuation Between GCK-MODY and Type 2 Diabetes Using Continuous Glucose Monitoring Technology

Dorzagliatin, a Dual-Acting Glucokinase Activator, Increases Insulin Secretion and Glucose Sensitivity in Glucokinase Maturity-Onset Diabetes of the Young and Recent-Onset Type 2 Diabetes

261-OR: Dorzagliatin, a Dual-Acting Glucokinase Activator. Improves Insulin Secretion and Glucose Sensitivity in Glucokinase-Maturity-Onset Diabetes of the Young (GCK-MODY)

182-OR: Clinical Effects of SGLT2 Inhibitors in HNF1A-Diabetes (MODY3) : A Case Series

1274-P: Prevalence and Clinical Characteristics of Monogenic Diabetes in Chinese Population

149-OR: Genetic Modulation of HNF1A Activity via SGLT2 Deficiency Leads to Transient Intermittent Hyperglycemia: Consequences for HNF1A-MODY

257-LB: A Novel MODY-Associated Gain-of-Function Mutation in TALK-1 Leads to Islet Dysfunction and Glucose Intolerance

1290-P: A Rare Case of HNF1A-MODY

Evaluation of Evidence for Pathogenicity Demonstrates That BLK, KLF11, and PAX4 Should Not Be Included in Diagnostic Testing for MODY

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

This Feature Is Available To Subscribers Only